These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 7731694
1. Human ERG is a proto-oncogene with mitogenic and transforming activity. Hart AH, Corrick CM, Tymms MJ, Hertzog PJ, Kola I. Oncogene; 1995 Apr 06; 10(7):1423-30. PubMed ID: 7731694 [Abstract] [Full Text] [Related]
2. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES. Oncogene; 1997 Mar 20; 14(11):1259-68. PubMed ID: 9178886 [Abstract] [Full Text] [Related]
3. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Watson DK, Smyth FE, Thompson DM, Cheng JQ, Testa JR, Papas TS, Seth A. Cell Growth Differ; 1992 Oct 20; 3(10):705-13. PubMed ID: 1445800 [Abstract] [Full Text] [Related]
4. erg, an ets-related gene, codes for sequence-specific transcriptional activators. Reddy ES, Rao VN. Oncogene; 1991 Dec 20; 6(12):2285-9. PubMed ID: 1766675 [Abstract] [Full Text] [Related]
5. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines. Simpson S, Woodworth CD, DiPaolo JA. Oncogene; 1997 May 08; 14(18):2149-57. PubMed ID: 9174050 [Abstract] [Full Text] [Related]
9. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Arvand A, Welford SM, Teitell MA, Denny CT. Cancer Res; 2001 Jul 01; 61(13):5311-7. PubMed ID: 11431376 [Abstract] [Full Text] [Related]
11. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins. Seth A, Robinson L, Panayiotakis A, Thompson DM, Hodge DR, Zhang XK, Watson DK, Ozato K, Papas TS. Oncogene; 1994 Feb 01; 9(2):469-77. PubMed ID: 7507230 [Abstract] [Full Text] [Related]
12. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule. Albor A, Thraves PJ, Dritschilo A, Notario V. Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522 [Abstract] [Full Text] [Related]
13. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ. Nat Genet; 1999 Oct 17; 23(2):222-7. PubMed ID: 10508522 [Abstract] [Full Text] [Related]
14. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Seth A, Robinson L, Thompson DM, Watson DK, Papas TS. Oncogene; 1993 Jul 17; 8(7):1783-90. PubMed ID: 8510925 [Abstract] [Full Text] [Related]
17. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Lessnick SL, Braun BS, Denny CT, May WA. Oncogene; 1995 Feb 02; 10(3):423-31. PubMed ID: 7845667 [Abstract] [Full Text] [Related]
18. Molecular analysis of the ets genes and their products. Watson DK, Ascione R, Papas TS. Crit Rev Oncog; 1990 Feb 02; 1(4):409-36. PubMed ID: 1964597 [Abstract] [Full Text] [Related]
19. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H. Cell Growth Differ; 1990 Sep 02; 1(9):407-20. PubMed ID: 1981145 [Abstract] [Full Text] [Related]
20. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS, Evans GA. J Clin Invest; 1994 Aug 02; 94(2):489-96. PubMed ID: 8040301 [Abstract] [Full Text] [Related] Page: [Next] [New Search]